(Q36538993)

14 August 2017

1 reference

title

Detrimental antidepressant drug-drug interactions: are they clinically relevant? (English)

1 reference

14 August 2017

0 references

Sheldon Preskorn

1

1 reference

PubMed ID

16847447

14 August 2017

Steve Werder

series ordinal

2

1 reference

PubMed ID

16847447

14 August 2017

language of work or name

English

0 references

publication date

1 August 2006

1 reference

14 August 2017

Neuropsychopharmacology

1 reference

14 August 2017

31

1 reference

14 August 2017

1605-12; discussion 1613

1 reference

14 August 2017

8

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.npp.1301070

14 August 2017

0 references

cites work

Organising evidence on QT prolongation and occurrence of Torsades de Pointes with non-antiarrhythmic drugs: a call for consensus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301070

Decreased plasma levels of amitriptyline and its metabolites on comedication with an extract from St. John's wort ( Hypericum perforatum ).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301070

The effects on performance of two antidepressants, alone and in combination with diazepam

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301070

Fatal interaction between tranylcypromine and imipramine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301070

Oral erythromycin and the risk of sudden death from cardiac causes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301070

Neurotoxic syndrome associated with risperidone and fluvoxamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301070

Serotonin syndrome and the combined use of deprenyl and an antidepressant in Parkinson's disease. Parkinson Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301070

Inhibition of risperidone metabolism by fluoxetine in patients with schizophrenia: a clinically relevant pharmacokinetic drug interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301070

Possible interaction between fluoxetine and pimozide causing sinus bradycardia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301070

7 January 2021

Tachycardia, orthostatic hypotension and profound weakness due to concomitant use of fluoxetine and nifedipine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301070

7 January 2021

Probable metabolic interaction between methadone and fluvoxamine in addict patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301070

7 January 2021

The CYP2D6 poor metabolizer phenotype may be associated with risperidone adverse drug reactions and discontinuation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301070

7 January 2021

Inhibition by fluoxetine of cytochrome P450 2D6 activity.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301070

7 January 2021

Syncope associated with concurrent amitriptyline and fluconazole therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301070

7 January 2021

Toxic Interaction Between Fluvoxamine and Sustained Release Theophylline in an 11-Year-Old Boy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301070

7 January 2021

Seizures and myoclonus associated with antidepressant treatment: assessment of potential risk factors, including CYP2D6 and CYP2C19 polymorphisms, and treatment with CYP2D6 inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301070

7 January 2021

Postoperative delirium indicating an adverse drug interaction involving the selective serotonin reuptake inhibitor, paroxetine?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301070

7 January 2021

Drug-induced torsade de pointes: from molecular biology to bedside.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301070

7 January 2021

Pharmacokinetic interactions of clozapine with selective serotonin reuptake inhibitors: differential effects of fluvoxamine and paroxetine in a prospective study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301070

7 January 2021

Identifiers

DOI

10.1038/SJ.NPP.1301070

1 reference

14 August 2017

1 reference

PubMed ID

16847447